Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral corticosteroids versus DMSO for inflammatory signs and symptoms in CRPS type 1
2010-019891-54Phase 3Active
- Sponsor
- VU University Medical Center
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisolone and Dimethyl sulfoxide in Complex Regional Pain Syndrome Type 1 (CRPS-1) (2 arms), sponsored by VU University Medical Center. Primary endpoint: Inflammatory Severity Score (ISS). Started Aug 2010; status: active.
02
Drugs
prednisoloneDimethyl sulfoxide
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2010-019891-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019891-54.